Research
Hormonal
Approximately 50% of diabetes remitters experience relapse at 20 years post-surgery.
Long-term monitoring is essential for patients who achieve remission to manage potential relapse.
StrongSupportsmedium confidence
At 20 years, approximately 50% of remitters have relapse of diabetes.
Why this rating
Based on long-term follow-up data mentioned in the abstract.
Source
An update on the role of bariatric surgery in diabetes management
Samir Malkani · Current Opinion in Endocrinology Diabetes and Obesity · 2015
DOI 10.1097/med.0000000000000143
reviewCited 10×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →